Carlsmed, Inc. CARL
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -43.62% | -55.34% | -51.79% | -82.48% | -7.79% |
| Total Depreciation and Amortization | 53.66% | 113.11% | 147.50% | 164.86% | 74.29% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 190.25% | 147.63% | 284.25% | 78.86% | 190.98% |
| Change in Net Operating Assets | 42.01% | 60.50% | -125.45% | 534.12% | -237.52% |
| Cash from Operations | -2.54% | -4.49% | -59.50% | -26.60% | -12.31% |
| Capital Expenditure | -77.99% | 63.00% | 4.82% | -19.67% | -1,823.53% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -722.83% | -5,562.61% | 18.06% | -- | -- |
| Cash from Investing | -423.91% | -2,825.15% | 13.45% | -39,621.31% | -3,852.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.61% | 614.71% | 192.62% | 200.00% | 209.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.94% | -- | -- | -- | -15,300.00% |
| Cash from Financing | -99.81% | 110.82% | -96.27% | 43.14% | -136.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -112.57% | -168.80% | -486.36% | -585.52% | -6,203.80% |